VanEck Associates’s Nucor NUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.5M Sell
62,074
-3,077
-5% -$536K 0.01% 587
2025
Q4
$10.6M Buy
65,151
+23,108
+55% +$3.47M 0.01% 542
2025
Q3
$5.69M Buy
42,043
+2,984
+8% +$422K 0.01% 719
2025
Q2
$5.06M Sell
39,059
-115,355
-75% -$13.5M 0.01% 731
2025
Q1
$18.6M Sell
154,414
-5,903
-4% -$761K 0.02% 330
2024
Q4
$18.7M Sell
160,317
-58,381
-27% -$8.4M 0.02% 334
2024
Q3
$31M Buy
218,698
+18,325
+9% +$2.76M 0.04% 239
2024
Q2
$31.7M Buy
200,373
+63,778
+47% +$11.1M 0.05% 213
2024
Q1
$27M Buy
136,595
+77,459
+131% +$14.2M 0.04% 230
2023
Q4
$10.3M Sell
59,136
-38,949
-40% -$6.18M 0.02% 365
2023
Q3
$15.3M Buy
98,085
+9,147
+10% +$1.51M 0.03% 284
2023
Q2
$14.6M Sell
88,938
-8,666
-9% -$1.27M 0.03% 292
2023
Q1
$15.1M Buy
97,604
+7,536
+8% +$1.2M 0.03% 288
2022
Q4
$11.9M Sell
90,068
-1,642
-2% -$223K 0.03% 313
2022
Q3
$9.81M Sell
91,710
-14,882
-14% -$1.87M 0.03% 310
2022
Q2
$11.1M Sell
106,592
-12,086
-10% -$1.64M 0.03% 314
2022
Q1
$17.6M Buy
118,678
+6,945
+6% +$852K 0.04% 273
2021
Q4
$12.8M Buy
111,733
+3,560
+3% +$389K 0.03% 324
2021
Q3
$10.7M Sell
108,173
-43,596
-29% -$4.63M 0.03% 339
2021
Q2
$14.6M Buy
151,769
+44,327
+41% +$4.15M 0.03% 297
2021
Q1
$8.62M Buy
107,442
+27,710
+35% +$1.68M 0.02% 365
2020
Q4
$4.24M Buy
79,732
+30,372
+62% +$1.57M 0.01% 408
2020
Q3
$2.21M Sell
49,360
-2,532
-5% -$112K 0.01% 467
2020
Q2
$2.15M Sell
51,892
-6,896
-12% -$279K 0.01% 472
2020
Q1
$2.12M Sell
58,788
-5,433
-8% -$241K 0.01% 443
2019
Q4
$3.61M Buy
64,221
+8,881
+16% +$484K 0.01% 417
2019
Q3
$2.82M Sell
55,340
-4,042
-7% -$211K 0.01% 425
2019
Q2
$3.27M Buy
59,382
+3,695
+7% +$203K 0.02% 398
2019
Q1
$3.25M Sell
55,687
-1,007
-2% -$59K 0.02% 393
2018
Q4
$2.94M Sell
56,694
-26,714
-32% -$1.58M 0.01% 383
2018
Q3
$5.29M Sell
83,408
-10,224
-11% -$655K 0.03% 310
2018
Q2
$5.85M Sell
93,632
-26,427
-22% -$1.69M 0.03% 284
2018
Q1
$7.33M Sell
120,059
-1,444
-1% -$95.6K 0.04% 260
2017
Q4
$7.72M Sell
121,503
-16,406
-12% -$960K 0.04% 248
2017
Q3
$7.73M Buy
137,909
+11,093
+9% +$627K 0.04% 256
2017
Q2
$7.34M Sell
126,816
-34,323
-21% -$2.01M 0.04% 248
2017
Q1
$9.62M Sell
161,139
-22,421
-12% -$1.37M 0.04% 228
2016
Q4
$10.9M Buy
183,560
+51,089
+39% +$2.86M 0.05% 210
2016
Q3
$6.55M Sell
132,471
-14,145
-10% -$720K 0.03% 252
2016
Q2
$7.24M Buy
146,616
+47,421
+48% +$2.31M 0.04% 224
2016
Q1
$4.69M Buy
99,195
+8,643
+10% +$352K 0.03% 226
2015
Q4
$3.65M Sell
90,552
-671
-0.7% -$27.6K 0.03% 256
2015
Q3
$3.42M Sell
91,223
-8,514
-9% -$365K 0.03% 264
2015
Q2
$4.39M Buy
99,737
+20,350
+26% +$977K 0.03% 280
2015
Q1
$3.77M Buy
79,387
+3,054
+4% +$143K 0.02% 297
2014
Q4
$3.74M Sell
76,333
-26,030
-25% -$1.35M 0.02% 290
2014
Q3
$5.56M Buy
102,363
+1,850
+2% +$97.6K 0.03% 235
2014
Q2
$4.95M Sell
100,513
-2,408
-2% -$124K 0.02% 249
2014
Q1
$5.2M Sell
102,921
-36,709
-26% -$1.84M 0.03% 233
2013
Q4
$7.45M Buy
139,630
+6,228
+5% +$321K 0.04% 207
2013
Q3
$6.54M Buy
133,402
+6,150
+5% +$288K 0.03% 205
2013
Q2
$5.51M Buy
+127,252
New +$5.64M 0.03% 206

Other funds holding NUE

VanEck Associates's NUE Position: Q1 2026 in Review

VanEck Associates reduced its Nucor (NUE) stake by 4.7% in Q1 2026, selling an estimated $536K and leaving 62,074 shares worth $10.5M. The position accounts for 0.01% of the portfolio, ranked #587.

VanEck Associates first reported a position in NUE in Q2 2013 and has held it in 52 quarters since. The position peaked at $31.7M in Q2 2024. 1,370 funds tracked by Wall St. Rank hold NUE as of Q1 2026.

  • VanEck Associates held 62,074 shares of Nucor worth $10.5M as of Q1 2026.
  • VanEck Associates sold 3,077 Nucor shares in Q1 2026, an estimated $536K.
  • Nucor made up 0.01% of VanEck Associates's portfolio in Q1 2026, its #587 holding.
  • VanEck Associates first reported a position in Nucor in Q2 2013 and has held it in 52 quarters since.
  • VanEck Associates's Nucor position peaked at $31.7M in Q2 2024.
  • 1,370 funds tracked by Wall St. Rank held Nucor as of Q1 2026.

Based on VanEck Associates's 13F filing for Q1 2026, filed 15 May 2026.